Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dixtal buys Respironics' pulse oximetry unit:

This article was originally published in Clinica

Executive Summary

Consistent with its strategy to divest non-core technologies, sleep and respiratory disorders company Respironics has sold its Novametrix pulse oximetry business to its long-term Brazilian manufacturing and marketing partner Dixtal Biomedica. Murrysville, Pennsylvania-based Respironics will retain its NICO2, Tidal Wave and CO2SMO pulse oximetry lines. Dixtal, which specialises in multi-parameter monitoring products, made the acquisition through its Dixtal Medical subsidiary. It has been selling the Novametrix products in Brazil for the last 15 years. Financial details of the transaction were not disclosed.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT049927

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel